Isoprenoid-mediated control of SMAD3 expression in a cultured model of cystic fibrosis epithelial cells

American Journal of Respiratory Cell and Molecular Biology

Volumn 31, Issue 2 I, 2004, Pages 234-240

  Lee, Jenny Y ^a   Elmer, Heather L ^a   Ross, Kristie R ^a   Kelley, Thomas J ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; DIMETHYLALLYLTRANSFERASE; FARNESYL TRANS TRANSFERASE; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOPRENOID; SMAD3 PROTEIN; STAT1 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; CYSTIC FIBROSIS; ENZYME ACTIVITY; ENZYME INHIBITION; EPITHELIUM CELL; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

BASE SEQUENCE; CELL LINE, TUMOR; CYSTIC FIBROSIS; DNA; DNA-BINDING PROTEINS; ENZYME INHIBITORS; EPITHELIAL CELLS; HUMANS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); SIGNAL TRANSDUCTION; SMAD3 PROTEIN; TERPENES; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 4143105723     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2003-0447OC     Document Type: Article

References (38)

1. MacLusky, I., and H. Levison. 1998. Cystic fibrosis. In Kendig's Disorders of the Respiratory Tract in Children, 6th ed. V. Chernick and T. Boat, editors. W. B. Saunders Company, Philadelphia. 838-876.
2. Davis, P., M. Drumm, and M. Konstan. 1996. Cystic fibrosis: state of the art. Am. J. Respir. Crit. Care Med. 154:1229-1256.
3. Konstan, M., and M. Berger. 1993. Infection and inflammation of the lung in cystic fibrosis. In Cystic Fibrosis. Lung Biology in Health and Disease, Vol. 64. P. Davis, editor. Marcel Dekker, New York. 219-276.
4. Balough, K., M. McCubbin, M. Weinerger, W. Smits, R. Ahrens, and R. Fick. 1995. The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis. Pediatr. Pulmonol. 20:63-70.
5. Konstan, M., and M. Berger. 1997. Current understanding of the inflammatory process in cystic fibrosis: onset and etiology. Pediatr. Pulmonol. 24:137-142.
6. Armstrong, D., K. Grimwood, R. Carzino, J. Gutierrez, J. Hull, A. Olinsky, E. Phelan, C. Roberston, and P. Phelan. 1995. Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis. BMJ 310:1571-1572.
7. Muhlebach, M., P. Stewart, M. Leigh, and T. Noah. 1999. Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients. Am. J. Respir. Crit. Care Med. 160:186-191.
8. Berger, M., and M. Konstan. 1999. Immunopathogenesis in cystic fibrosis lung disease. In Cystic Fibrosis in Adults. T. Yankaskas and M. Knowles, editors. Lippincott-Raven, Philadelphia. 115-141.
9. Khan, T., J. Wagener, T. Bost, J. Martinez, F. Accurso, and D. Riches. 1995. Early pulmonary inflammation in infants with cystic fibrosis. Am. J. Respir. Crit. Care Med. 151:1075-1082.
10. Chmiel, J., M. Konstan, J. Knesebeck, J. Milliard, T. Bonfield, D. Dawson, and M. Berger. 1999. IL-10 attenuates excessive inflammation in chronic Pseudomonas infection in mice. Am. J. Respir. Crit. Care Med. 160:2040-2047.
11. Bonfield, T., J. Panuska, M. Konstan, K. Hilliard, J. Milliard, H. Ghnaim, and M. Berger. 1995. Inflammatory cytokines in cystic fibrosis lungs. Am. J. Respir. Crit. Care Med. 152:2111-2118.
12. Bonfield, T., M. Konstan, P. Burfeind, J. Panuska, J. Hilliard, and M. Berger. 1995. Normal bronchial epithelial cells constitutively produce the antiinflammatory cytokine inerleukin-10, which is downregulated in cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 13:257-261.
13. Osika, E., J. Cavaillon, K. Chadelat, M. Boule, C. Fitting, G. Tournier, and A. Clement. 1999. Distinct sputum cytokine profiles in cystic fibrosis and other chronic inflammatory airway disease. Eur. Respir. J. 14:339-346.
14. Robers, A., and M. Sporn. 1993. Physiological action and clinical applications of transforming growth factor beta. Growth Factors 8:1-9.
15. Barnard, J., R. Lyons, and H. Mosies. 1990. The cell biology of transforming growth factor β. Biochim. Biophys. Acta 1032:79-87.
16. Whitman, M. 1998. Smads and early developmental signaling by the TGF-β superfamily. Genes Dev. 12:2445-2462.
17. Arkwright, P., S. Laurie, M. Super, V. Pravica, M. Schwarz, A. Webb, and I. Hutchinson. 2000. TGF-β1 genotype and accelerated decline in lung function of patients with cystic fibrosis. Thorax 55:459-462.
18. Lewindon, P., T. Pereira, A. Hoskins, K. Bridle, R. Williamson, R. Shepherd, and G. Ramm. 2002. The role of hepatic stellate cells and transforming growth factor-β1 in cystic fibrosis liver disease. Am. J. Pathol. 160:1705-1715.
19. Massague, J., and Y. G. Chen. 2000. Controlling TGF-β signaling. Genes Dev. 14:627-644.
20. Heldin, C., K. Miyazono, and P. Dijke. 1997. TGF-β signaling from cell membrane to nucleus through Smad proteins. Nature 390:465-471.
21. Kelley, T., H. Elmer, and D. Corey. 2001. Reduced SMAD3 protein expression and altered transforming growth factor-β1-mediated signaling in cystic fibrosis epithelial cells. Am. J. Respir. Cell Mol. Biol. 25:732-738.
22. Kreiselmeier, N. E., N. C. Kraynack, D. A. Corey, and T. J. Kelley. 2003. Statin-mediated correction of STAT1 signaling and inducible nitric oxide synthase expression in cystic fibrosis epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 285:L1286-L1295.
23. Molnar, G., M. Dagher, M. Geiszt, J. Settleman, and E. Ligeti. 2001. Role of prenylation in the interaction of rho-family small GTPases with GTPase activating proteins. Biochemistry 40:542-549.
24. Adnane, J., F. Bizouarn, Y. Qian, A. Hamilton, and S. M. Sebti. 1998. P21 (WAF1/CIP1) is up regulated by the geranylgeranyltransferase I inhibitor GGTI-298 through a transforming growth factor beta- and Sp1-responsive element: involvement of the small GTPase rhoA. Mol. Cell. Biol. 18:6962-6970.
25. Park, H., and J. Galper. 1999. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors up-regulate transforming growth factor-β signaling in cultured heart cells via inhibition of geranylgeranylation of RhoA GTPase. Proc. Natl. Acad. Sci. USA 96:11525-11530.
26. Perez, A., K. Risma, E. Eckman, and P. Davis. 1996. Over expression of R domain eliminates camp-stimulated Cl-secretion in 9/HTEo-cells in culture. Am. J. Physiol. 217:L35-L92.
27. Lerner, E. C., Y. Qian, M. A. Blaskovich, R. D. Fossum, A. Vogt, J. Sun, A. D. Cox, C. J. Der, A. D. Hamilton, and S. M. Sebti. 1995. Ras CAAX peptidomimetic FTI-277 selectively blocks oncogenic Ras signaling by inducing cytoplasmic accumulation of inactive Ras-Raf complexes. J. Biol. Chem. 270:26802-26806.
28. Lerner, E. C., Y. Qian, A. D. Hamilton, and S. M. Sebti. 1995. Disruption of oncogenic K-Ras4B processing and signaling by a potent geranylgeranyl- transferase I inhibitor. J. Biol. Chem. 270:26770-26773.
29. Lesh, R. E., C. W. Emala, H. T. Lee, D. Zhu, R. A. Panettieri, and C. A. Hirshman. 2001. Inhibition of gernylgeranylation blocks agonist-induced actin reorganization in human airway smooth muscle cells. Am. J. Physiol. Lung Cell Mol. Physiol. 281:L824-L831.
30. Blume, S. W., R. C. Snyder, R. Ray, S. Thomas, C. A. Koller, and D. M. Miller. 1991. Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. J. Clin. Invest. 88:1613-1621.
31. Greenwel, P., Y. Inagaki, W. Hu, M. Walsh, and F. Ramirez. 1997. Sp1 is required for the early response of alpha2(I) collagen to transforming growth factor-beta1. J. Biol. Chem. 272:19738-19745.
32. Krikun, G., F. Schatz, N. Mackman, S. Guller, R. Demopoulos, and C. J. Lockwood. 2000. Regulation of tissue factor gene expression in human endometrium by transcription factors Sp1 and Sp3. Mol. Endocrinol. 14: 393-400.
33. Kucich, U., J. C. Rosenbloom, G. Shen, W. R. Abrams, A. D. Hamilton, S. M. Sebti, and J. Rosenbloom. 2000. TGF-beta1 stimulation of fibronectin transcription in cultured human lung fibroblasts requires active geranylgeranyl transferase I, phosphatidylcholine-specific phospholipase C, protein kinase C-delta, and p38, but not erk1/erk2. Arch. Biochem. Biophys. 374:313-324.
34. Bulus, N. M., H. M. Sheng, N. Sizemore, S. M. Oldham, J. V. Barnett, R. J. Coffey, D. R. Beauchamp, and J. A. Barnard. 2000. Ras-mediated suppression of TGFbetaRII expression in intestinal epithelial cells involves Raf-independent signaling. Neoplasm 2:357-364.
35. Boujaoude, L. C., C. Bradshaw-Wilder, C. Mao, J. Cohn, B. Ogretmen, Y. A. Hannun, and L. M. Obeid. 2001. Cystic fibrosis transmembrane regulator regulates uptake of sphingoid base phosphates and lysophosphatidic acid: modulation of cellular activity of sphmgosine 1-phosphate. J. Biol. Chem. 276:35258-35264.
36. Freedman, S. D., M. H. Katz, E. M. Parker, M. Laposata, M. Y. Urman, and J. G. Alvarez. 1999. A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr(-/-) mice. Proc. Natl. Acad. Sci. USA 96:13995-14000.
37. Soltys, J., T. Bonfield, J. Chmiel, and M. Berger. 2002. Functional IL-10 deficiency in the lung of cystic fibrosis (cftr(-/-)) and IL-10 knockout mice causes increased expression and function of B7 co-stimulatory molecules on alveolar macrophages. J. Immunol. 168:1903-1910.
38. Tone, M., M. J. Powell, Y. Tone, S. A. Thompson, and H. Waldmann. 2000. IL-10 gene expression is controlled by the transcription factors Sp1 and Sp3. J. Immunol. 165:286-291.